Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Liposomal Bupivacaine for Pain Control Following Mastectomy and Breast Reconstruction

NCT03722927 is registered in ClinicalTrials.gov with Wake Forest University Health Sciences as lead sponsor.

NCT NCT03722927
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03722927 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Liposomal Bupivacaine for Pain Control Following Mastectomy and Breast Reconstruction
Lead sponsor
Wake Forest University Health Sciences
Phase
Phase 4
Overall status
Completed
Start date
June 14, 2018
Completion date
January 29, 2020
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pain, breast